Proteins with commercially available, phosphorylation site-specific, antibodies.
Listing 442 proteins.
| Protein Name | Gene Symbol | Alternate Names | # of Sites | # of Antibodies | |
|---|---|---|---|---|---|
 |
14-3-3 beta | YWHAB | 14-3-3 beta; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta; 14-3-3 alpha; | 1 | 1 |
|
14-3-3 epsilon | YWHAE | 14-3-3 epsilon; 14-3-3E; protein kinase C inhibitor protein-1; PKC inhibitor protein-1; mitochondrial import stimulation factor L subunit; mt import stimulation factor L subunit; KCIP-1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; | 1 | 1 |
|
14-3-3 eta | YWHAH | 14-3-3 eta; PROTEIN KINASE C INHIBITOR PROTEIN-1; KCIP-1; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta; | 1 | 1 |
|
14-3-3 gamma | YWHAG | 14-3-3 gamma; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma; | 1 | 1 |
|
14-3-3 zeta | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; 14-3-3 zeta; 14-3-3 delta; | 1 | 1 |
|
4E-BP1 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1; 4E-BP1; phosphorylated heat- and acid-stable protein; PHAS-1; | 5 | 16 |
|
5-lipoxygenase | ALOX5 | arachidonate 5-lipoxygenase; 5-LO; | 1 | 1 |
|
53BP1 | TP53BP1 | tumor protein 53-binding protein 1; 53bp1; | 3 | 5 |
|
A-Raf | ARAF1 | A-Raf; | 1 | 1 |
|
abl1 | ABL1 | abelson strain of murine leukemia viral oncogene homolog 1; abl1; c-abl; abl; p150; | 3 | 8 |
|
Acetyl-CoA Carboxylase | ACACA | acetyl-CoA carboxylase; abll; | 1 | 2 |
|
Actopaxin | PARVA | parvin alpha; Actopaxin; | 1 | 2 |
|
AFX | MLLT7 | AFX; forkhead box O4; FOXO4; myeloid/lymphoid or mixed-lineage leukemia translocated to 7; MLLT7; | 3 | 2 |
|
AIP4 | ITCH | atrophin-1 interacting protein 4; itchy homolog E3 ubiquitin protein ligase; ITCH; | 1 | 1 |
|
Akt1 | AKT1 | protein Kinase B; PKB; Akt1; AKT; C-AKT; RAC-alpha serine/threonine kinase; RAC; rac alpha; rac-pk alpha; | 3 | 27 |
|
Akt2 | AKT2 | Akt2; rac pk beta; racb; | 2 | 3 |
|
AKT3 | AKT3 | AKT3; protein kinase B gamma; PKBgamma; | 2 | 3 |
|
alpha adducin | ADD1 | alpha adducin; | 2 | 3 |
|
alpha B crystallin | CRYAB | alpha B crystallin; | 2 | 3 |
|
alpha filamin | FLNA | alpha-filamin; actin-binding protein-280; ABP-280; filamin-1; | 1 | 2 |
|
alpha synuclein | SNCA | alpha synuclein; non-A-beta component of Alzheimer disease amyloid precursor; NACP; | 2 | 2 |
|
AMPK alpha 1 | PRKAA1 | AMP-activated protein kinase alpha 1; AMPKalpha-1; | 2 | 7 |
|
AMPK alpha 2 | PRKAA2 | AMP-activated protein kinase alpha 2; | 2 | 6 |
|
AMPK beta 1 | PRKAB1 | AMP-activated protein kinase beta 1; | 2 | 3 |
|
androgen receptor | AR | androgen receptor; AR; | 2 | 2 |
|
APC1 | ANAPC1 | anaphase-promoting complex 1; | 2 | 2 |
|
APC6 | CDC16 | Anaphase promoting complex 6; cdc16 homolog; | 1 | 1 |
|
APP | APP | amyloid beta (A4) precursor protein; APP; | 1 | 2 |
|
AS160 | TBC1D4 | TBC1 domain family, member 4; TBC1D4; | 1 | 1 |
|
ASAP1 | DDEF1 | development and differentiation enhancing factor 1; DDEF1; ASAP1; | 1 | 1 |
|
ASK-1 | MAP3K5 | MEKK5; Apoptosis signal-regulating kinase 1; ASK-1; ASK; MAPKKK5; MAP3K5; | 3 | 4 |
|
ATF2 | ATF2 | activating transcription factor 2; ATF2; cAMP-response element-binding protein-2; CRE-BP2; | 5 | 15 |
|
ATM | ATM | ataxia-telangiectasia mutated; ATM; ATM kinase; | 1 | 4 |
|
ATP citrate lyase | ACLY | ATP citrate lyase; ATP-citrate (pro-S-)-lyase; Citrate cleavage enzyme; | 1 | 1 |
|
ATR | ATR | ataxia telangiectasia and Rad3 related; ATR; | 1 | 1 |
|
Aurora A | STK6 | serine/threonine kinase 15; STK15; BTAK; Aurora-A kinase; Aurora A; STK6; | 1 | 1 |
|
B-ATF | BATF | basic leucine zipper transcription factor, ATF-like; BATF1; SFA-2; | 2 | 3 |
|
B-Myb | MYBL2 | v-myb myeloblastosis viral oncogene homolog (avian)-like 2; | 4 | 4 |
|
B-Raf | BRAF | B-Raf; BRAF; Raf-B1; B-Raf1; RMIL serine/threonine-protein kinase; | 3 | 3 |
|
B23 | NPM1 | NUCLEOPHOSMIN; NPM; B23; numatrin; | 1 | 1 |
|
bad | BAD | Bcl-2-antagonist of cell death; Bcl-2 binding component 6; | 4 | 14 |
|
Bcl-2 | BCL2 | B cell leukemia 2; Bcl-2; B cell lymphoma 2; | 4 | 6 |
|
bcl-3 | BCL3 | B cell lymphoma 3; B cell leukemia 3; | 2 | 2 |
|
Bcl-XL | BCL2L1 | Bcl-XL; BCL2-like 1; | 1 | 2 |
|
BCR | BCR | breakpoint cluster region; BCR; | 1 | 3 |
|
beta-1 integrin | ITGB1 | CD29; GP; ITGB1; Platelet GPIIa; Integrin VLA-4 beta subunit; VLA-beta chain; fibronectin receptor beta subunit; FNRB; | 3 | 3 |
|
beta-2 integrin | ITGB2 | CD18; CD11a beta subunit; CD11b beta subunit; CD11c beta subunit; beta-2 integrin; beta2; beta 2; beta-2 integrin chain; | 3 | 3 |
|
beta-3 integrin | ITGB3 | CD61; platelet glycoprotein IIIa; GPIIb/IIIa; GP3A; antigen CD61; CD61A; | 2 | 5 |
|
beta-4 integrin | ITGB4 | CD104; beta 4 integrin chain; tumor specific protein 180 antigen; TSP-1180; | 2 | 2 |
|
beta-adducin | ADD2 | beta adducin; | 1 | 2 |
|
beta-arrestin1 | ARRB1 | beta-arrestin1; BArrestin1; | 1 | 4 |
|
beta-catenin | CTNNB1 | beta catenin; | 7 | 15 |
|
beta-dystroglycan | DAG1 | beta-dystroglycan; beta-DG; dystrophin-associated glycoprotein 1; DAG1; 156DAG; A2; alpha dystroglycan; | 1 | 2 |
|
beta2-adrenergic receptor | ADRB2 | beta2-adrenergic receptor; beta 2-AR; | 7 | 9 |
|
BID | Bid | 2 | 2 | |
|
BIM EL isoform | BCL2L11 | Bcl-2 interacting mediator; | 2 | 3 |
|
blnk | BLNK | B cell linker protein; blnk; slp-65; | 2 | 4 |
|
BRCA1 | BRCA1 | breast cancer type 1; BRCA1; | 9 | 12 |
|
Btk | BTK | Bruton's tyrosine kinase; Btk; B-cell progenitor kinase; bpk; agammaglobulinemia tyrosine kinase; atk; | 3 | 5 |
|
c-Fos | FOS | cell FBJ murine osteosarcoma; fos; | 2 | 2 |
|
c-Kit | KIT | CD117; stem cell factor receptor; SCFR; | 7 | 14 |
|
c-myb | MYB | v-myb avian myeloblastosis viral oncogene homolog; myb; efg; | 2 | 2 |
|
c-myc | MYC | c-myc; | 2 | 6 |
|
c-Raf | RAF1 | c-Raf; raf-1; mil; Raf1; | 10 | 22 |
|
c-Ret | RET | ret proto-oncogene; Ret; | 3 | 3 |
|
c-src | SRC | cellular src; src; c-src; phosphoprotein 60 c-src; pp60c-src; pp60src; human homolog of v-src; Rous sarcoma virus; avian sarcoma virus; ASV; | 4 | 15 |
|
c-yes | YES1 | c-yes; yes; p62-yes; | 1 | 3 |
|
C/EBP alpha | CEBPA | CCAAT/enhancer binding protein alpha; C/EBP alpha; | 3 | 3 |
|
C/EBP beta | CEBPB | CCAAT/enhancer binding protein beta; C/EBP beta; | 1 | 1 |
|
C3G | RAPGEF1 | CRK SH3 domain-binding guanine nucleotide-releasing factor; | 1 | 1 |
|
CAD | CAD | carbamoyl-phosphate synthetase 2; PYR1; | 1 | 1 |
|
caldesmon 1 | CALD1 | caldesmon 1; caldesmon; NAG22; | 2 | 2 |
|
calmodulin 1 | CALM1 | calmodulin 1; | 6 | 7 |
|
Calponin 1 | CNN1 | basic calponin; smooth muscle calponin; | 1 | 1 |
|
CAMK I | CAMK1 | calcium/calmodulin-dependent protein kinase I; CAMK I; | 1 | 1 |
|
CAMKII alpha | CAMK2A | calcium/calmodulin-dependent protein kinase II alpha; | 2 | 6 |
|
CAMKII beta | CAMK2B | calcium/calmodulin-dependent protein kinase II beta; CAMKII beta; | 2 | 4 |
|
CAMKII delta | CAMK2D | calcium/calmodulin-dependent protein kinase II delta; CAMKII delta; | 2 | 4 |
|
CAMKII gamma | CAMK2G | calcium/calmodulin-dependent protein kinase II gamma; CAMKII gamma; | 2 | 4 |
|
CAMKIV | CAMK4 | calcium/calmodulin-dependent protein kinase IV; CAMK IV; | 1 | 1 |
|
caspase-9 | CASP9 | caspase-9; apoptotic protease activating factor 3; APAF-3; | 2 | 2 |
|
caveolin-1 | CAV1 | caveolin-1; VIP21; caveolin; | 1 | 3 |
|
caveolin-2 | CAV2 | caveolin-2; | 1 | 1 |
|
CB1 | CNR1 | CB1 cannabinoid receptor; CANN6; CB1K5; CNR; | 1 | 1 |
|
cbl | CBL | cbl; p120 cbl; c-Cbl; | 3 | 7 |
|
CD130 | IL6ST | CD130; IL-6R-gp130SIG; IL-6R beta; IL-6ST; gp130; | 1 | 4 |
|
CD131 | CSF2RB | CD131; CDw131; common beta subunit; IL-3RB; IL-3Rbeta; IL-5RB; IL-5Rbeta; CSF2RB; CSF-2Rbeta; | 1 | 1 |
|
CD19 | CD19 | CD19; B4; | 1 | 1 |
|
CD22 | CD22 | CD22; BL-CAM; Lyb8; | 3 | 3 |
|
CD246 | ALK | anaplastic lymphoma kinase 1; alk1; Ki-1; CD246; | 2 | 2 |
|
CD32B | FCGR2B | Fcgamma receptor IIB; FcgammaRIIb; CD32B; | 1 | 1 |
|
CD45 | PTPRC | CD45; B220; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; EC 3.1.3.4; Leukocyte Common Antigen; LCA; T200; Ly5; | 1 | 1 |
|
CDC25C | CDC25C | cell division cycle 25C; CDC25C; | 4 | 9 |
|
cdc27 | CDC27 | cdc27; | 1 | 1 |
|
cdc42 | CDC42 | cdc42 homolog; cdc42; G25K GTP-BINDING PROTEIN, PLACENTAL ISOFORM; GP; CLA4; | 1 | 2 |
|
cdc6 | CDC6 | cdc6; | 2 | 2 |
|
cdk1 | CDC2 | cyclin-dependent kinase 1; CDK1; cell division control protein 2 homolog; cdc2; p34 protein kinase; | 3 | 10 |
|
cdk2 | CDK2 | cell division protein kinase 2; CDK2; p33; | 2 | 2 |
|
CENP-A | CENPA | centromere protein A; CENP-A; | 1 | 2 |
|
Chk1 | CHEK1 | Checkpoint kinase; Chk1; | 4 | 7 |
|
Chk2 | CHEK2 | Chk2; Rad53; | 9 | 11 |
|
CKII beta | CSNK2B | Casein kinase II beta; CK2b; | 1 | 1 |
|
cofilin 1 | CFL1 | cofilin 1; cofilin non-muscle isoform; | 1 | 3 |
|
cofilin 2 | CFL2 | cofilin 2; cofilin muscle isoform; | 1 | 1 |
|
connexin 43 | GJA1 | connexin 43; | 1 | 2 |
|
COT | MAP3K8 | cancer osaka thyroid oncogene; cCOT; MEKK8; Tpl-2; mitogen-activated protein kinase kinase kinase 8; MAP3K8; | 1 | 1 |
|
CPI-17 | PPP1R14A | CPI-17; | 1 | 1 |
|
cPLA2-alpha | PLA2G4A | cPLA2-alpha; PLA2 IVA; | 1 | 1 |
|
CREB-alpha | CREB1 | cyclic AMP response element binding protein 1; CREB; CREB 1; | 2 | 11 |
|
CREB-delta | CREB1 | cyclic AMP response element binding protein 1; CREB; CREB 1; | 2 | 11 |
|
Crk | CRK | Crk; c-Crk; | 1 | 2 |
|
CrkL | CRKL | CrkL; v-crk avian sarcoma virus CT10 oncogene homolog-like; | 1 | 2 |
|
CSF-1R | CSF1R | CD115; c-fms; colony stimulating factor 1R; macrophage colony stimulating factor receptor; M-CSFR; | 3 | 4 |
|
cyclin B1 | CCNB1 | cyclin B1; | 2 | 2 |
|
cyclin D1 | CCND1 | cyclin D1; CCND1; | 1 | 1 |
|
cyclin E | CCNE1 | cyclin E; cyclin E1; | 1 | 1 |
|
dab1 | DAB1 | disabled homolog 1; dab1; | 4 | 5 |
|
Dab2 | DAB2 | Differentially expressed in Ovarian Cancer 2; DOC2; disabled homolog 2, mitogen-responsive phosphoprotein; DAB2; | 1 | 1 |
|
DAPK2 | DAPK2 | death-associated protein kinase 2; DAP-kinase 2; | 1 | 1 |
|
DARPP-32 | PPP1R1B | dopamine and cAMP regulated phosphoprotein; DARPP-32; | 2 | 6 |
|
delta 1 catenin | CTNND1 | delta 1 catenin; p120 catenin; | 3 | 4 |
|
DNA-PKcs | PRKDC | DNA-dependent protein kinase catalytic subunit; DNA-PKcs; DNA-PK; | 1 | 1 |
|
dok2 | DOK2 | docking protein 2; p56DOK; p56dok-2; | 1 | 1 |
|
DOR-1 | OPRD1 | delta opiod receptor 1; DOR-1; | 1 | 1 |
|
dynamin-1 | DNM1 | dynamin-1; dynamin; | 1 | 1 |
|
E2A | TCF3 | TCF3; Transcription Factor E2-Alpha; Immunoglobulin Enhancer Binding Factor E12; immunoglobulin transcription factor; ITF1; | 1 | 1 |
|
E2F1 | E2F1 | E2F transcription factor 1; | 1 | 1 |
|
ECT2 | ECT2 | epithelial cell transforming sequence 2; ECT2; Pebble; | 1 | 1 |
|
eEF2K | EEF2K | calmodulin-dependent protein kinase III; CAMK III; elongation factor-2 kinase; eEF-2 kinase; | 4 | 5 |
|
EGFR | EGFR | epidermal growth factor receptor; EGFR; ErbB-1; HER1; | 9 | 26 |
|
eIF2A | EIF2S1 | eukaryotic translation initiation factor 2, subunit 1 (alpha, 35kDa); eIF-2 alpha; eIF2A; | 1 | 4 |
|
eIF2B5 | EIF2B5 | eIF2B5; eIF2B epsilon; | 1 | 1 |
|
eIF4B | EIF4B | eukaryotic translation initiation factor 4B; | 1 | 1 |
|
eIF4E | EIF4E | eukaryotic translation initiation factor 4E; EIF4E; eIF-4E; mRNA cap-binding protein; | 1 | 3 |
|
eIF4G | EIF4G1 | eukaryotic translation initiation factor 4 gamma; eIF-4G; | 1 | 2 |
|
ELK1 | ELK1 | ELK1; ETS-DOMAIN PROTEIN; | 1 | 6 |
|
elongation factor-2 | EEF2 | elongation factor-2; EEF-2; EF-2; | 1 | 1 |
|
ephrin-B1 | EFNB1 | ephrin-B1; EFL-3; Elk-L; LERK-2; lerk2; STRA-1; cek5-L; | 4 | 5 |
|
ephrin-B2 | EFNB2 | ephrin-B2; ELF-2; LERK-5; lerk5; NLERK-1; htk-L; | 3 | 3 |
|
ephrin-B3 | EFNB3 | ephrin-B3; EFL-6; ELF-3; LERK-8; lerk8; NLERK-2; elk-L3; | 3 | 3 |
|
EPOR | EPOR | erythropoietin receptor; | 1 | 1 |
|
ER-alpha | ESR1 | estrogen receptor alpha; ER-alpha; estrogen receptor 1; | 6 | 15 |
|
ER-beta | ESR2 | estrogen receptor beta; ER-beta; | 1 | 2 |
|
ErbB-3 | ERBB3 | erythroblastic leukemia viral oncogene homolog 3; ErbB-3; tyrosine kinase type cell surface receptor her3; her3; | 1 | 1 |
|
ErbB-4 | ERBB4 | erythroblastic leukemia viral oncogene homolog 4; ErbB-4; her4; | 2 | 2 |
|
erk1 | MAPK3 | extracellular signal-regulated kinase 1; ERK1; mitogen activated protein kinase 3; MAPK3; | 2 | 36 |
|
erk2 | MAPK1 | extracellular signal-regulated kinase 2; ERK2; mitogen activated protein kinase 1; MAPK1; | 2 | 34 |
|
erk5 | MAPK7 | extracellular signal-regulated kinase 5; ERK5; mitogen-activated protein kinase 7; MAPK7; protein kinase, mitogen-activated 7; PRKM7; big mitogen-activated protein (MAP) kinase-1; BMK1; | 2 | 8 |
|
ETK | BMX | ETK; BMX non-receptor tyrosine kinase; | 1 | 1 |
|
Ets-1 | ETS1 | Ets-1; | 4 | 5 |
|
Ets-2 | ETS2 | Ets-2; | 1 | 1 |
|
ezrin | VIL2 | Ezrin; VILLIN-2; cytovillin; pp81; | 3 | 7 |
|
FADD | FADD | fas associating death domain containing protein; FADD; | 1 | 3 |
|
FAK | PTK2 | focal adhesion kinase; FAK; FADK; pp125fak; focal adhesion kinase 1; FAK1; | 9 | 26 |
|
FANCD2 | FANCD2 | Fanconi anemia, complementation group D; | 1 | 1 |
|
FANCG | FANCG | Fanconi anemia, complementation group G; | 1 | 1 |
|
FGFR1 | FGFR1 | FMS-like tyrosine kinase 2; flt2; fibroblast growth factor receptor 1; FGFR1; | 3 | 11 |
|
FGFR3 | FGFR3 | fibroblast growth factor receptor 3; | 1 | 1 |
|
FHIT | FHIT | fragile histidine triad gene; | 1 | 1 |
|
FKHR | FOXO1A | forkhead homolog 1; forkhead box O1; Fox01; | 5 | 14 |
|
FKHRL1 | FOXO3A | forkhead like 1; FKHRL1; | 4 | 7 |
|
FLT3 | FLT3 | CD135; FMS-like tyrosine kinase 3; Flk-2; STK-1; | 4 | 6 |
|
FRS2 | FRS2 | fibroblast growth factor receptor substrate 2; | 2 | 2 |
|
fyn | FYN | fyn; P59-fyn; slk; syn; | 3 | 6 |
|
GAB1 | GAB1 | GRB2-associated binding protein 1; GAB1; | 2 | 5 |
|
GAB2 | GAB2 | GRB2-associated binding protein 2; GAB2; | 2 | 2 |
|
GABA Receptor 2 | GPR51 | gamma-aminobutyric acid B receptor 2; | 1 | 2 |
|
gamma adducin | ADD3 | gamma adducin; | 1 | 2 |
|
gamma-catenin | JUP | desmoplakin III; DPIII; DP3; plakoglobin; | 1 | 1 |
|
gamma-filamin | FLNC | gamma-filamin; filamin 2; | 1 | 1 |
|
gap-43 | GAP43 | growth associated protein; Axonal Membrane Protein.PP46; B-50; Calmodulin-Binding Protein P-57; Protein F1; neuromodulin; | 1 | 3 |
|
GATA-4 | GATA4 | Transfection factor GATA-4; GATA-4; | 2 | 2 |
|
GCN2 | EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4; EIF2AK4; general control non-derepressible-2; | 1 | 1 |
|
GCR | NR3C1 | glucocorticoid receptor; GR; GCR; nuclear receptor subfamily 3, group C, member 1; GRL; | 1 | 1 |
|
GluR1 | GRIA1 | glutamate receptor, ionotropic 1; glutamate receptor, ionotropic, AMPA 1; AMPA-1; GLURA; | 3 | 3 |
|
GluR2 | GRIA2 | glutamate receptor, ionotropic, AMPA 2; GLUR2; | 1 | 1 |
|
GluR3 | GRIA3 | glutamate receptor, ionotrophic, AMPA 3; | 1 | 1 |
|
GLUT4 | SLC2A4 | GLUCOSE TRANSPORTER TYPE 4; GLUT4; | 1 | 1 |
|
glycogen synthase 1 | GYS1 | glycogen synthase 1; GYS1; muscle glycogen synthase; | 1 | 2 |
|
GM130 | GOLGA2 | Golgi matrix 130; GM130; | 1 | 1 |
|
grb10 | GRB10 | growth factor receptor-bound protein 10; grb10; | 1 | 1 |
|
GRK2 | ADRBK1 | beta adrenergic receptor kinase 1; bARK1; ADRBK1; EC 2.7.1.126; beta-ARK-1; g-protein dependent receptor kinase 2; | 1 | 1 |
|
GSK-3alpha | GSK3A | glycogen synthase kinase-3 alpha; GSK-3alpha; | 2 | 11 |
|
GSK-3beta | GSK3B | glycogen synthase kinase-3 beta; GSK-3beta; Zw3; | 2 | 11 |
|
hck | HCK | hemopoietic cell kinase; hck; p59-hck; p60-hck; | 3 | 6 |
|
HER-2 | ERBB2 | erythroblastic leukemia viral oncogene homolog 2; ErbB-2; HER-2; neu; | 5 | 9 |
|
histone H2AX | H2AFX | histone H2A.X; H2A histone family, member X; | 1 | 4 |
|
histone H2B | HIST1H2BK | H2B histone family, member T; | 1 | 4 |
|
histone H3.1 | H3F3A | H3 histone family 3A; | 5 | 27 |
|
histone H3.3 | H3F3B | H3 histone, family 3B; H3.3B; | 6 | 26 |
|
histone H4 | HIST1H4D | 1 | 1 | |
|
hnRNP A0 | HNRPA0 | Heterogeneous nuclear ribonucleoprotein A0; | 1 | 1 |
|
hnRNP K | HNRPK | heterogeneous nuclear ribonucleoprotein K; hnRNP K; | 1 | 1 |
|
HSF1 | HSF1 | HEAT SHOCK FACTOR PROTEIN 1; HSF1; | 1 | 1 |
|
HSL | LIPE | lipase, hormone-sensitive; LIPE; hormone-sensitive lipase; | 3 | 3 |
|
HSP27 | HSPB1 | heat shock 25kD protein 1; hsp25 protein 1; heat shock protein 27 protein 1; HSP27; hsp28; | 3 | 14 |
|
huntingtin | HD | huntingtin; Huntington; | 1 | 1 |
|
IGFI-R | IGF1R | insulin-like growth factor I receptor; IGFI-R; | 3 | 5 |
|
IkB alpha | NFKBIA | I kappa B alpha; IkBa; IkappaBalpha; | 6 | 18 |
|
IkB beta | NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; IkBb; IkappaB beta; | 2 | 2 |
|
IkB epsilon | NFKBIE | IkB epsilon; IkappaB-epsilon; | 2 | 2 |
|
IKKalpha | CHUK | inhibitor of kappa light polypeptide gene enhancer in B-cells alpha; IKKalpha; NFKBIKA; conserved helix-loop-helix ubiquitous kinase; CHUK; | 3 | 9 |
|
IKKbeta | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells; IKKbeta; IKBKB; I-kappa-b kinase 2; IKK2; | 3 | 9 |
|
IKKepsilon | IKBKE | IKK-related kinase epsilon; IKKepsilon; | 1 | 1 |
|
IKKgamma | IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; Nf-KB essential modulator; NEMO; | 1 | 2 |
|
Inhibitor-2 | PPP1R2 | protein phosphatase inhibitor 2; ipp2; | 2 | 3 |
|
integrin alpha4 | ITGA4 | CD49d; VLA-4 alpha; | 1 | 1 |
|
interferon alpha receptor 1 | IFNAR1 | interferon alpha receptor 1; IFNaR1; | 3 | 3 |
|
ipp1 | PPP1R1A | protein phosphatase inhibitor 1; ipp1; inhibitor-1; inh-1; | 2 | 2 |
|
IR | INSR | insulin receptor; IR; INSR; | 4 | 14 |
|
IRAK-1 | IRAK1 | interleukin-1 receptor-associated kinase 1; IRAK-1; | 1 | 1 |
|
IRF3 | IRF3 | interferon regulatory factor 3; | 2 | 3 |
|
IRS-1 | IRS1 | insulin-receptor signaling 1; insulin receptor substrate 1; IRS-1; | 21 | 35 |
|
IRS-2 | IRS2 | insulin receptor substrate-2; | 3 | 3 |
|
itk | ITK | IL-2 inducible T-cell kinase; itk; T-cell specific kinase; tsk; emt; lyk; | 1 | 1 |
|
jak1 | JAK1 | janus kinase 1; JAK1; | 2 | 6 |
|
jak2 | JAK2 | janus kinase 2; JAK2; | 3 | 13 |
|
JAK3 | JAK3 | janus kinase 3; jak3; | 1 | 1 |
|
JAM-1 | F11R | junctional adhesion molecule 1; JAM-1; JAM; F11; | 1 | 1 |
|
JNK1 | MAPK8 | jun N-terminal kinase1; JNK1; c-Jun N-terminal kinase 1; mitogen activated protein kinase 8; MAPK8; protein kinase, mitogen-activated 8; PRKM8; stress activated protein kinase JNK1; SAPK1; | 2 | 19 |
|
jnk2 | MAPK9 | jun N-terminal kinase 2; JNK2; c-Jun N-terminal kinase 2; mitogen activated protein kinase 9; MAPK9; protein kinase, mitogen-activated 9; PRKM9; stress-activated protein kinase JNK2; SAPK2; | 2 | 11 |
|
jnk3 | MAPK10 | jun N-terminal kinase 3; JNK3; | 2 | 9 |
|
jun | JUN | jun; c-jun; v-jun; AP-1; | 4 | 20 |
|
KAP-1 | TRIM28 | KRAB-associated Protein 1; KAP1; Tripartite Motif-containing 28; TRIM28; Transcriptional Intermediary Factor 1-beta; TF1B; TIF1B; | 1 | 2 |
|
Keratin 8 | KRT8 | keratin K8; K8; type II cytoskeletal keratin K8; | 1 | 1 |
|
KID | KIF22 | kinesin-like 4; kinesin-like DNA binding protein; | 1 | 1 |
|
KSR1 | KSR | kinase suppressor of Ras 1; KSR1; KSR; ceramide activated kinase; | 1 | 1 |
|
Kv4.2 | KCND2 | potassium voltage-gated channel, Shal-related subfamily, member 2; Kv4.2; | 3 | 4 |
|
LAT | LAT | linker for activation of T cells; LAT; p36/38; p38; pp36/38; | 4 | 9 |
|
lck | LCK | Lck; p56lck; lymphocyte specific protein tyrosine kinase; | 5 | 12 |
|
Leptin receptor | LEPR | leptin receptor; LEPR; Ob receptor; Ob-R; | 2 | 3 |
|
LIMK-1 | LIMK1 | LIM Domain Kinase-1; LIM Kinase-1; | 2 | 3 |
|
LIMK-2a | LIMK2 | LIM domain kinase 2; LIMK-2; | 2 | 3 |
|
LKB1 | STK11 | LKB1; serine/threonine kinase 11; STK11; Peutz-Jeghers syndrome kinase; | 3 | 4 |
|
LRP6 | LRP6 | low density lipoprotein receptor-related protein 6; | 1 | 1 |
|
lyn | LYN | lyn; p53lyn; p56lyn; | 2 | 6 |
|
MAG | MAG | myelin-associated glycoprotein; MAG; | 1 | 1 |
|
MAP2 | MAP2 | microtubule-associated protein 2; | 3 | 3 |
|
MAPKAP-K2 | MAPKAPK2 | MAP kinase-activated protein kinase 2; MAPKAP-K2; MK2; | 3 | 6 |
|
MAPKAP-K5 | MAPKAPK5 | mitogen-activated protein kinase-activated protein kinase 5; MAPKAP-K5; p38-related/activated protein kinase; PRAK; | 1 | 2 |
|
MARCKS | MARCKS | myristoylated alanine-rich protein kinase C substrate; MARCKS; PKCSL; | 2 | 10 |
|
MARK1 | MARK1 | MAP/microtubule affinity-regulating kinase 1; PAR-1c; hPAR-1c; | 1 | 1 |
|
MARK2 | MARK2 | ELKL motif kinase; MAP/microtubule affinity-regulating kinase 2; PAR-1b; hPAR-1b; EMK; | 1 | 1 |
|
MARK3 | MARK3 | MAP/microtubule affinity-regulating kinase 3; MARK3; kp78; Cdc25C associated protein kinase C-TAK1; PAR-1a; hPAR-1a; | 1 | 1 |
|
MBP | MBP | myelin basic protein; MBP; | 1 | 1 |
|
MCM2 | MCM2 | minichromosome maintenance deficient 2; MCM2; mitotin; cdc19; | 5 | 10 |
|
MDM2 | MDM2 | mouse double minute 2; MDM2; | 1 | 1 |
|
MDM4 | MDM4 | mouse double minute 4; HdmX; MdmX; p53 binding protein; | 1 | 1 |
|
MEF2A | MEF2A | Myocyte Enhancer Factor 2A; | 1 | 1 |
|
MEF2B | MEF2B | Myocyte Enhancer Factor 2B; | 1 | 1 |
|
MEF2C | MEF2C | myocyte enhancer factor 2C; | 2 | 2 |
|
MEF2D | MEF2D | Myocyte Enhancer Factor 2D; | 1 | 1 |
|
MEK1 | MAP2K1 | MEK1; MKK1; | 6 | 25 |
|
MEK2 | MAP2K2 | MAPK/ERK kinase 2; MEK2; MKK2; MAP kinase kinase 2; MAPKK2; | 3 | 16 |
|
merlin | NF2 | merlin; schwannomin; neurofibromatosis type 2 tumor suppressor gene; NF2; | 1 | 1 |
|
MET | MET | met proto-oncogene precursor; MET; c-Met; hepatocyte growth factor receptor; HGFR; | 6 | 16 |
|
MKK3 | MAP2K3 | MKK3; MAPKK3; MEK3; | 2 | 4 |
|
MKK6 | MAP2K6 | MKK6; MEK6; MAPKK6; | 2 | 4 |
|
MKK7 | MAP2K7 | MAP kinase kinase 7; mitogen-activated protein kinase kinase 7; MAP2K7; MAPK/ERK kinase 7; MEK7; | 2 | 7 |
|
MKP1 | DUSP1 | MAPK phosphatase-1; dual specificity phosphatase 1; DUSP1; | 1 | 1 |
|
MLCB | MRCL3 | myosin, light polypeptide, regulatory, non-sarcomeric; MLCB; | 2 | 10 |
|
MLCK | MYLK | myosin light chain kinase; myosin, light polypeptide kinase; | 1 | 1 |
|
MLF1 interacting protein | MLF1IP | MLF1 interacting protein; MLF1IP; CENPU; CENP-U; CENP-U(50); CENP-50; KLIP1; FLJ23468; | 1 | 1 |
|
MLK3 | MAP3K11 | mixed lineage kinase-3; MLK3; Src homology 3 domain (SH3)-containing proline-rich protein kinase; SPRK; MAP3K11; PTK1; | 2 | 4 |
|
MNK1 | MKNK1 | MAP kinase-interacting serine/threonine kinase 1; MNK1; | 2 | 2 |
|
moesin | MSN | MEMBRANE-ORGANIZING EXTENSION SPIKE PROTEIN; moesin; pasin 2; | 1 | 3 |
|
MOR-1 | OPRM1 | opioid receptor, mu 1; MOR-1; | 1 | 1 |
|
MRLC2 | MRLC2 | myosin regulatory light chain 2; MRLC2; | 2 | 10 |
|
MSK1 | RPS6KA5 | mitogen- and stress-activated protein kinase 1; MSK1; p90-RSK5; | 3 | 5 |
|
MST1 | STK4 | mammalian Ste-20 like kinase 1; MST1; STK4; | 1 | 1 |
|
MST2 | STK3 | serine/threonine kinase 3; STK3; KRS1; mammalian Ste-20 like kinase 2; MST2; | 1 | 1 |
|
mTOR | FRAP1 | FK506 binding protein 12-rapamycin associated protein; FRAP; mammalian target of rapamycin; mTOR; TOR; RAFT1; | 2 | 4 |
|
MYPT1 | PPP1R12A | myosin-binding subunit of myosin phosphatase; MBS of myosin phosphatase; MYPT1; M110; | 4 | 6 |
|
MYRL2 | MYL9 | MYOSIN REGULATORY LIGHT CHAIN 2, Smooth Muscle; MYRL2; MYOSIN REGULATORY LIGHT CHAIN 2, NONSARCOMERIC; light chain 20; LC20; | 2 | 10 |
|
Myt1 kinase | PKMYT1 | membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase; MAP3K3; | 1 | 1 |
|
N-cadherin | CDH2 | neural cadherin; N-cadherin; | 2 | 3 |
|
N-myc | MYCN | v-myc avian myelocytomatosis viral related oncogene neuroblastoma derived; Neuroblastoma Myc-related oncogene 1; nMyc; nMyc-1; | 1 | 1 |
|
N-WASP | WASL | Neural Wiskott-Aldrich Syndrome Protein; | 3 | 5 |
|
NAK | TBK1 | NF-kB-activating kinase; NAK; TANK-binding kinase 1; TBK1; T2K; | 1 | 1 |
|
NBS1 | NBS1 | Nijmegen breakage syndrome 1; p95; nibrin; | 1 | 4 |
|
neurogranin | NRGN | neurogranin; RC3; | 1 | 1 |
|
NFATc2 | NFATC2 | nuclear factor of activated T-cells 1; NFAT1; NFATp; | 5 | 5 |
|
NFATc4 | NFATC4 | NFATc4; | 6 | 6 |
|
NFkappa B | NFKB1 | NFkappa B; NFBK1; KBF1; p105; p50/p105; | 1 | 3 |
|
NG2 | CSPG4 | melanoma-associated chondroitin sulfate proteoglycan 4; MCSP; | 1 | 1 |
|
NIK | MAP3K14 | nuclear factor kappaB-inducing kinase; MEKK14; MAPKKK14; | 1 | 1 |
|
NMDA Receptor NR2B Subunit | GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B; GRIN2B; NMDA Receptor NR2B Subunit; | 4 | 4 |
|
NMDAR1 | GRIN1 | N-methyl D-aspartate receptor 1; NMDAR1; glutamate receptor zeta 1; | 3 | 8 |
|
NOS1 | NOS1 | Nitric oxide synthase 1; NOS1; | 2 | 2 |
|
NOS3 | NOS3 | nitric oxide synthetase 3; NOS3; endothelial NOS; eNOS; | 3 | 10 |
|
NSP3 | SH2D3C | CAS/HEF1 associated signal transducer; Chat-H; SH2 domain-containing Eph receptor-binding protein 1; SHEP1; novel SH2-containing protein 3; | 1 | 1 |
|
Nur77 | NR4A1 | Nuclear Hormone Receptor 77; N10 nuclear protein; TR3; | 2 | 3 |
|
oncoprotein 18 | STMN1 | oncoprotein 18; Lleukemia-associated phosphoprotein p18; metablastin; phosphoprotein p19; pp19; pp17; pr22 protein; prosolin; Stathmin; | 2 | 2 |
|
p120 rasGAP | RASA1 | p120 rasGAP; p120rasGAP; p120 GAP; p120GAP; | 1 | 1 |
|
p130 | RBL2 | retinoblastoma-like 2; rb2; p130; | 4 | 5 |
|
p130CAS | BCAR1 | Crk-associated substrate p130Cas; p130CAS; CAS; | 4 | 5 |
|
p21 | CDKN1A | cyclin-dependent kinase inhibitor 1A; CIP1; waf1; p21CIP; p21WAF1; MDA-6; | 2 | 2 |
|
p27 | CDKN1B | p27; cyclin-dependent kinase inhibitor 1B; CDKN1B; Kip1; p27kip; p27kip1; | 2 | 4 |
|
p38-alpha | MAPK14 | p38 MAPK; p38-alpha; CSAID binding protein1; CSBP1; mitogen-activated protein kinase 14; MAPK14; MAX-interacting protein 2; MXI2; SAPK2A; | 2 | 27 |
|
p40-phox | NCF4 | neutrophil cytosolic factor 4; NCF4; | 1 | 2 |
|
p53 | TP53 | p53; cellular tumor antigen p53; phosphoprotein p53; | 15 | 31 |
|
p57 Kip2 | CDKN1C | cyclin-dependent kinase inhibitor 1C; Kip2; p57 Kip2; p57Kip2; p57; | 1 | 1 |
|
p63 | TP73L | p63; TAp63; | 4 | 4 |
|
p70S6K-alpha | RPS6KB1 | p70S6K-alpha; ribosomal S6 kinase 1; RSK1; S6K1; STK14alpha; | 6 | 17 |
|
p70S6K-beta | RPS6KB2 | ribosomal protein S6 kinase beta; S6K-beta; p70S6 kinase beta; S6K2; RSK2; S6K-related kinase; SRK; | 2 | 3 |
|
p73 | TP73 | tumor protein p73; p73; | 1 | 2 |
|
p90-RSK1 | RPS6KA1 | ribosomal protein S6 kinase, 90kD, polypeptide 1; p90-RSK1; MAPKAP-K1; | 4 | 12 |
|
p90-RSK2 | RPS6KA3 | p90-RSK2; INSULIN-STIMULATED PROTEIN KINASE 1; ISPK-1; ribosomal protein S6 kinase, 90kD, polypeptide 3; | 5 | 10 |
|
p90-RSK3 | RPS6KA2 | ribosomal protein S6 kinase, 90kD, polypeptide 2; p90-RSK2; p90-RSK3; MAPKAPK1B; | 4 | 7 |
|
PAG3 | DDEF2 | paxillin-associated protein with ADP-ribosylation factor [ARF] GTPase-activating protein activity 3; KIAA0400; development and differentiation enhancing factor 2; DDEF2; Papalpha; AMAP2; | 2 | 2 |
|
PAK1 | PAK1 | alpha-PAK; alpha pak; pak-alpha; p21 activated kinase 1; PAK1; p65pak; | 4 | 12 |
|
PAK2 | PAK2 | gamma p21-activated kinase; gamma pak; hPAK65; PAK65; S6/H4 kinase; p21-activated kinase 2; PAK2; auto-phosphorylation dependent kinase; auto-kinase; | 5 | 11 |
|
PAK3 | PAK3 | beta p21-activated kinase; beta pak; p21-activated kinase 3; PAK3; | 2 | 5 |
|
PAK4 | PAK4 | p21-activated kinase 4; PAK4; | 1 | 1 |
|
PAK5 | PAK7 | p21-activated kinase 5; PAK5; | 1 | 1 |
|
PAK6 | PAK6 | p21-activated kinase 6; PAK6; | 2 | 2 |
|
paxillin | PXN | paxillin; PXN; | 10 | 16 |
|
PDCD4 | PDCD4 | programmed cell death 4 (neoplastic transformation inhibitor); nuclear antigen H731; | 1 | 1 |
|
PDGFR-alpha | PDGFRA | CD140a; PDGF Receptor; PDGF-R; PDGFR; alpha platelet-derived growth factor receptor; PDGFa; | 7 | 9 |
|
PDGFR-beta | PDGFRB | CD140b; beta platelet-derived growth factor receptor; PDGFb; | 10 | 35 |
|
PDK1 | PDPK1 | upstream PKB kinase; USK; Protein kinase B kinase; PKBK; phospholipid-dependent protein kinase 1; PDK1; 3-phosphoinositide dependent protein kinase-1; phosphorylated by 3-phosphoinositide-dependent kinase 1; | 2 | 3 |
|
PEA15 | PEA15 | phosphoprotein enriched in diabetes; PED; phosphoprotein enriched in astrocytes 15-kDa; | 1 | 1 |
|
PERK | EIF2AK3 | PRKR-like endoplasmic reticulum kinase; PERK; eukaryotic translation initiation factor 2-alpha kinase 3; | 1 | 3 |
|
phosducin | PDC | phosducin; | 1 | 1 |
|
PIM-1 | PIM1 | PIM-1; | 1 | 1 |
|
PIN1 | PIN1 | protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1; PIN1; | 1 | 1 |
|
PKA alpha catalytic subunit | PRKACA | cAMP-dependent protein kinase alpha; cAPKa; PRKACA; alpha-catalytic subunit; PKA c-alpha; | 1 | 2 |
|
PKA beta catalytic subunit | PRKACB | cAMP-dependent protein kinase beta; beta-catalytic subunit PKA; PKA C-beta; | 2 | 3 |
|
PKA gamma catalytic subunit | PRKACG | cAMP-dependent protein kinase gamma; gamma-catalytic subunit PKA; PKA C-gamma; | 1 | 2 |
|
PKA RII alpha | PRKAR2A | PKA regulatory subunit Type II alpha; PKA RII alpha; | 1 | 2 |
|
PKA RII beta | PRKAR2B | PKA regulatory subunit Type II beta; PKA RII beta; | 1 | 2 |
|
pkc-alpha | PRKCA | pkc-alpha; | 4 | 11 |
|
PKC-beta1 | PRKCB1 | pkc-beta; PRKCB1; | 4 | 7 |
|
PKC-beta2 | PRKCB1 | pkc-beta; PRKCB1; | 3 | 6 |
|
pkc-delta | PRKCD | pkc-delta; | 4 | 8 |
|
pkc-epsilon | PRKCE | pkc-epsilon; | 2 | 5 |
|
pkc-eta | PRKCH | pkc-eta; PKC-l; nPKC-eta; | 3 | 5 |
|
pkc-gamma | PRKCG | pkc-gamma; | 3 | 5 |
|
pkc-iota | PRKCI | pkc-iota; PKC-lambda; PRKCI; nPKC-iota; | 2 | 3 |
|
pkc-theta | PRKCQ | pkc-theta; | 3 | 7 |
|
pkc-zeta | PRKCZ | pkc-zeta; PRKCZ; nPKC-zeta; | 2 | 4 |
|
PKD1 | PRKD1 | protein kinase D; PKD; PRKCM; nPKC-mu; pkc-mu; protein kinase D 1; PKD1; | 3 | 6 |
|
PKD2 | PRKD2 | PKD-related 1; PKDR1; PKD2; | 3 | 4 |
|
PKD3 | PRKD3 | PKC-nu; PKD3; | 2 | 3 |
|
PKR | PRKR | interferon inducible double stranded RNA protein kinase; PKR; PKRK; P1/EIF-2A protein kinase; p68 protein kinase; | 2 | 7 |
|
PLC-beta3 | PLCB3 | phospholipase C, beta 3; PLC-beta3; | 2 | 2 |
|
PLC-gamma 1 | PLCG1 | phospholipase C gamma-1; PLC-gamma 1; PLC1; PLCG1; phospholipase C-148; PLC148; | 5 | 9 |
|
PLC-gamma 2 | PLCG2 | phospholipase C gamma-2; PLC-gamma 2; | 2 | 2 |
|
PLD1 | PLD1 | phospholipase D1, phophatidylcholine-specific; phophatidylcholine-specific phospholipase D; PC-PLD; | 2 | 3 |
|
PLK-1 | PLK1 | Polo-Like Kinase-1; PLK-1; PLK; serine-threonine protein kinase 13; stpk13; | 1 | 1 |
|
PP1c alpha | PPP1CA | protein phosphatase 1, catalytic subunit, alpha isoform; PP1c alpha; | 1 | 1 |
|
PP1c delta | PPP1CB | PP1c beta; PP1c delta; | 1 | 1 |
|
PP1c gamma | PPP1CC | PP1c gamma; | 1 | 1 |
|
PP2Ac alpha | PPP2CA | protein phosphatase 2 - a isoform; PP2c alpha; PP2A alpha catalytic; PP2Ac alpha; | 1 | 1 |
|
PP2Ac beta | PPP2CB | PP2c beta; PP2A beta catalytic; PP2Ac beta; | 1 | 1 |
|
PPAR-gamma | PPARG | peroxisome proliferative activated receptor, gamma; | 1 | 1 |
|
PRAS40 | AKT1S1 | proline-rich Akt substrate 40; PRAS; | 1 | 2 |
|
PRK1 | PKN1 | Protein kinase C-related kinase-1; PRK1; protein kinase N; PKN; PKNalpha; | 1 | 3 |
|
PRK2 | PKN2 | Protein kinase C-related kinase-2; PRK2; | 1 | 3 |
|
progesterone receptor | PGR | progesterone receptor; | 2 | 4 |
|
PTEN | PTEN | phosphatase and tensin homolog; PTEN; PTEP1; TEP; TEP1; mutated in multiple advanced cancers 1; MMAC1; | 5 | 18 |
|
PTP-alpha | PTPRA | protein tyrosine phosphatase, receptor type, alpha; RPTP-alpha; LCA-related phosphatase; LRP; HLRP; PTPalpha; | 1 | 1 |
|
pyk2 | PTK2B | proline-rich tyrosine kinase 2; Pyk2; CAKbeta; calcium-dependent tyrosine kinase related adhesion focal tyrosine kinase; CADTK; related adhesion focal tyrosine kinase; RAFTK; | 4 | 9 |
|
Rac1 | RAC1 | RAS-related C3 botulinium toxin substrate 1; Rac1; | 1 | 3 |
|
RAD17 | RAD17 | RAD17 homolog; RAD17; | 2 | 4 |
|
Radixin | RDX | Radixin; | 1 | 3 |
|
RAP74 | GTF2F1 | TAF IIF, polypeptide 1; TF2F1; TFIIF; RNA polymerase II-associating protein 74; BTF4; | 2 | 2 |
|
rb | RB1 | retinoblastoma protein; Rb; pRB; | 13 | 34 |
|
RelA | RELA | reticuloendotheliosis viral oncogene homolog A; RelA; nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65); p65Rel; p65; | 5 | 11 |
|
RGS9 light sensitive isoform | RGS9 | regulator of G-protein signalling 9; RGS9; | 1 | 1 |
|
Rho-GDI alpha | ARHGDIA | RHO GDP-DISSOCIATION INHIBITOR 1; Rho-GDI alpha; rho-GDI 1; | 1 | 1 |
|
RhoA | RHOA | RhoA; Rho A; | 1 | 2 |
|
RKIP | PBP | Raf kinase inhibitor protein; RKIP; prostatic binding protein; phosphatidylethanolamine binding protein; PEBP; Neuropolypeptide h3; Hippocampal cholinergic neurostimulating peptides; HNCP; | 1 | 1 |
|
RNA polymerase II | POLR2A | RNA polymerase II; | 2 | 4 |
|
ROK-alpha | ROCK2 | Rho-associated, coiled-coil containing protein kinase 2; ROCK-2; Rho-associated kinase-alpha; ROK-alpha; Rho-kinase; | 1 | 1 |
|
RON | MST1R | CDw136; macrophage stimulating protein receptor; msp receptor; RON; p158-ron; | 4 | 6 |
|
RPA2 | RPA2 | replication protein A2; RPA32; REPA2; 32 kDa; RFA2; RPA-p34; | 3 | 3 |
|
S6 ribosomal protein | RPS6 | ribosomal protein S6; phosphoprotein NP33; | 5 | 20 |
|
SEK1 | MAP2K4 | MAP KINASE KINASE 4; MKK4; MAP2K4; MAPK/ERK kinase 4; MEK4; | 3 | 7 |
|
SGK1 | SGK | serum- and glucocorticoid-regulated protein kinase; SGK1; SGK; | 3 | 4 |
|
SH3BP2 | SH3BP2 | 3BP2; SH3BP2; | 1 | 1 |
|
SHC | SHC1 | src homology 2 domain-containing; ShcA; Shc52; p66Shc; Shc66; Shc46; | 4 | 14 |
|
SHIP-1 | INPP5D | SH2-containing inositol 5 phosphatase-1; SHIP-1; SHIP; | 1 | 1 |
|
SHP-1 | PTPN6 | Src homology 2 domain phosphatase-1; SHP-1; protein tyrosine phosphatase 1C; PTP1C; PTP-N6; SHPTP-1; hematopoietic cell phophatase; HCP; | 2 | 2 |
|
SHP-2 | PTPN11 | SHP-2; protein tyrosine phosphatase 1D; PTP1D; SYP; SH-PTP2; | 3 | 5 |
|
slp-76 | LCP2 | SH2 domain-containing leukocyte protein of 76kD; slp-76; lymphocyte cytosolic protein 2; LCP2; 76-kDa phosphoprotein; pp76; 76-kDa Vav-associated protein; | 3 | 3 |
|
SMAD1 | SMAD1 | SMAD1; | 2 | 10 |
|
SMAD2 | SMAD2 | SMAD2; | 6 | 14 |
|
SMAD3 | SMAD3 | SMAD3; | 2 | 8 |
|
SMAD5 | SMAD5 | SMAD5; | 2 | 2 |
|
SMC1 | SMC1L1 | SMC1L1; SMC1; | 2 | 7 |
|
SMC3 | CSPG6 | SMC3; | 2 | 3 |
|
SRF | SRF | serum response factor; SRF; | 1 | 1 |
|
STAT1 | STAT1 | signal transducer and activator of transcription 1; STAT1; transcription factor ISGF-3 components p91/p84; ISGF-3; | 2 | 12 |
|
STAT2 | STAT2 | Signal Transducers and Activators of Transcription 2; STAT2; | 1 | 3 |
|
STAT3 | STAT3 | signal transducer and activator of transcription; STAT3; acute-phase response factor; APRF; | 2 | 17 |
|
STAT4 | STAT4 | Signal Transducers and Activators of Transcription 4; STAT4; | 2 | 4 |
|
STAT5A | STAT5A | Signal Transducers and Activators of Transcription 5a; STAT5A; mammary gland factor; MGF; | 4 | 14 |
|
STAT5B | STAT5B | Signal Transducers and Activators of Transcription 5b; STAT5B; | 3 | 12 |
|
STAT6 | STAT6 | Signal Transducers and Activators of Transcription 6; STAT6; | 1 | 9 |
|
STXBP1 | STXBP1 | Hunc18; syntaxin-binding protein 1; Sec1p; n-sec1; Munc-18-1; rbSec1; unc18; | 1 | 1 |
|
survivin | BIRC5 | apoptosis inhibitor 4; AIP4; | 1 | 2 |
|
syk | SYK | spleen tyrosine kinase; syk; p72syk; | 5 | 9 |
|
Synapsin IA | SYN1 | BRAIN PROTEIN 4.1; SYNAPSIN IA; SYNAPSIN IB; Synapsin I; | 3 | 5 |
|
Synapsin IB | SYN1 | BRAIN PROTEIN 4.1; SYNAPSIN IA; SYNAPSIN IB; Synapsin I; | 3 | 5 |
|
synaptotagmin I | SYT1 | synaptotagmin I; Syt I; p65 synaptotagmin; | 2 | 2 |
|
synaptotagmin II | SYT2 | synaptotagmin II; | 2 | 2 |
|
synaptotagmin III | SYT3 | synaptotagmin III; Syt3; | 1 | 1 |
|
synaptotagmin IV | SYT4 | synaptotagmin IV; | 1 | 1 |
|
synaptotagmin V | SYT5 | synaptotagmin V; Syt5; synaptotagmin 5; | 1 | 1 |
|
syndecan-4 | SDC4 | syndecan-4; SYND4; SDC4; amphiglycan; ryudocan core protein; ryudocan; | 1 | 1 |
|
TAK1 | MAP3K7 | transforming growth factor beta-activated kinase 1; TAK1; TGF-beta activated kinase 1; mitogen-activated protein kinase kinase kinase 7; MAPKKK7; MEKK7; MAP3K7; | 3 | 7 |
|
TAL-1 | TAL1 | T-cell acute lymphocytic leukemia 1; stem cell leukemia hematopoietic transcription factor; SCL; stem cell protein; T-cell leukemia/lymphoma 5; TCL5; | 1 | 1 |
|
TAO2 | TAOK2 | thousand and one amino acid protein kinase 2; prostate derived STE20-like kinase; PSK; kinase from chicken-C; KFC-C; hKFC-C; | 1 | 1 |
|
tau | MAPT | MAP tau; microtubule-associated protein tau; MAPT; MTBT1; paired helical filament-tau; PHF-tau; neurofibrillary tangle protein; | 15 | 17 |
|
TAZ | WWTR1 | transcriptional co-activator with PDZ-binding motif; TAZ; | 1 | 1 |
|
TCR-zeta | CD3Z | TCR-zeta; | 1 | 1 |
|
Tie2 | TEK | tunic interna endothelial cell kinase; TEK; tunic interna endothelial 2; CD202b; | 1 | 2 |
|
TLK1 | TLK1 | SNARE-kinase; SNAK; tousled-like kinase 1; | 1 | 1 |
|
TLR3 | TLR3 | TLR3; | 1 | 1 |
|
TOP2 alpha | TOP2A | Topoisomerase II, alpha enzyme; EC 5.99.1.3; | 1 | 1 |
|
TOPK | TOPK | T-cell-originated protein kinase; TOPK; PDZ-domain binding kinase; PBK; | 1 | 1 |
|
trkA | NTRK1 | transforming tyrosine kinase; trkA; trk1; p140-trka; high affinity nerve growth factor receptor; ntrk1; neurotrophic tyrosine kinase receptor, type 1; | 3 | 5 |
|
trkB | NTRK2 | tyrosine kinase receptor B; trkB; trk2; gp145-trkB; BDNF NT-3 growth factors receptor precursor; neurotrophic tyrosine kinase receptor, type 2; ntrk2; | 2 | 2 |
|
troponin I, cardiac | TNNI3 | troponin I, cardiac; TnI; | 2 | 2 |
|
tryptophan hydroxylase | TPH1 | 2 | 2 | |
|
tsc2 | TSC2 | tuberous sclerosis 2; tuberin; | 4 | 7 |
|
tyk2 | TYK2 | non-receptor tyrosine kinase 2; tyk2; | 2 | 6 |
|
tyrosine hydroxylase | TH | tyrosine hydroxylase; | 3 | 4 |
|
VASP | VASP | VASP; | 2 | 5 |
|
Vav | VAV1 | vav; vav1; p95vav; | 1 | 2 |
|
Vav2 | VAV2 | vav2; | 1 | 1 |
|
Vav3 | VAV3 | vav3; | 1 | 2 |
|
VE-cadherin | CDH5 | CD144; VE-cadherin; cadherin-5; | 2 | 2 |
|
VEGFR-2 | KDR | vascular endothelial growth factor receptor 2; Flk-1; CD309; | 6 | 16 |
|
vimentin | VIM | vimentin; | 3 | 3 |
|
vinculin | VCL | vinculin; | 4 | 3 |
|
WASP | WAS | Wiskott Aldrich Syndrome Protein; WASP; | 2 | 6 |
|
WNK1 | PRKWNK1 | protein kinase, lysine deficient 1; KDP; WNK1; | 1 | 1 |
|
XRCC1 | XRCC1 | X-ray Repair Complementing protein 1; | 7 | 7 |
|
YAP1 | YAP1 | yes-associated protein 1; yes-associated protein p65; YAP65; | 1 | 1 |
|
ZAP-70 | ZAP70 | zeta-associated protein 70; zap-70; syk related tyrosine kinase; srk; | 4 | 12 |